Literature DB >> 16178850

Clinical uses of intravenous immunoglobulin.

S Jolles1, W A C Sewell, S A Misbah.   

Abstract

Mesh：

Substances：

Year:  2005        PMID： 16178850      PMCID： PMC1809480          DOI： 10.1111/j.1365-2249.2005.02834.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  120 in total

1.  Polyvalent immunoglobulin for intravenous use interferes with cell proliferation in vitro.

Authors:  I N van Schaik; I Lundkvist; M Vermeulen; A Brand
Journal:  J Clin Immunol       Date:  1992-09       Impact factor: 8.317

2.  Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment].

Authors:  S Takei; Y K Arora; S M Walker
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

3.  Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.

Authors:  S Klaesson; O Ringdén; L Markling; M Remberger; I Lundkvist
Journal:  Scand J Immunol       Date:  1993-11       Impact factor: 3.487

4.  Immunologically active proteins in intravenous immunoglobulin.

Authors:  L Lam; C F Whitsett; J M McNicholl; T W Hodge; J Hooper
Journal:  Lancet       Date:  1993-09-11       Impact factor: 79.321

5.  Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.

Authors:  J J Marchalonis; H Kaymaz; F Dedeoglu; S F Schluter; D E Yocum; A B Edmundson
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-15       Impact factor: 11.205

6.  Intravenous immune globulin in chronic lymphocytic leukaemia.

Authors:  H Gamm; C Huber; H Chapel; M Lee; F Ries; M A Dicato
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

7.  Antibodies to the CD5 molecule in normal human immunoglobulins for therapeutic use (intravenous immunoglobulins, IVIg).

Authors:  T Vassilev; C Gelin; S V Kaveri; M T Zilber; L Boumsell; M D Kazatchkine
Journal:  Clin Exp Immunol       Date:  1993-06       Impact factor: 4.330

8.  Down-regulation of cytokine production and interleukin-2 receptor expression by pooled human IgG.

Authors:  U G Andersson; L Björk; U Skansén-Saphir; J P Andersson
Journal:  Immunology       Date:  1993-06       Impact factor: 7.397

9.  Intravenous immunoglobulin induces interferon-gamma and interleukin-6 in vivo.

Authors:  Z D Ling; E Yeoh; B T Webb; K Farrell; J Doucette; D S Matheson
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

10.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
View more
  94 in total

1.  Normal IgG downregulates the intracellular superoxide level and attenuates migration and permeability in human aortic endothelial cells isolated from a hypertensive patient.

Authors:  Xiuqing Wang; Qianyu Wang; Zhongjie Sun
Journal:  Hypertension       Date:  2012-07-09       Impact factor: 10.190

Review 2.  Intravenous immunoglobulin: an update on the clinical use and mechanisms of action.

Authors:  Vir-Singh Negi; Sriramulu Elluru; Sophie Sibéril; Stéphanie Graff-Dubois; Luc Mouthon; Michel D Kazatchkine; Sébastien Lacroix-Desmazes; Jagadeesh Bayry; Srini V Kaveri
Journal:  J Clin Immunol       Date:  2007-03-11       Impact factor: 8.317

3.  Response of refractory immune thrombocytopenic purpura in a patient with common variable immunodeficiency to treatment with rituximab.

Authors:  T M El-Shanawany; P E Williams; S Jolles
Journal:  J Clin Pathol       Date:  2007-05-04       Impact factor: 3.411

Review 4.  Discovery of protective B-cell epitopes for development of antimicrobial vaccines and antibody therapeutics.

Authors:  Jacqueline Sharon; Michael J Rynkiewicz; Zhaohua Lu; Chiou-Ying Yang
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 5.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

6.  Intravenous immunoglobulin in pediatrics: A review.

Authors:  A N Prasad; Sanjay Chaudhary
Journal:  Med J Armed Forces India       Date:  2013-08-06

7.  Toxic epidermal necrolysis from a cigarette burn.

Authors:  Joshua R Parker; Ross P Berkeley
Journal:  West J Emerg Med       Date:  2010-05

8.  Switching Patients to Home-Based Subcutaneous Immunoglobulin: an Economic Evaluation of an Interprofessional Drug Therapy Management Program.

Authors:  Clemence Perraudin; Aline Bourdin; Francois Spertini; Jérôme Berger; Olivier Bugnon
Journal:  J Clin Immunol       Date:  2016-05-02       Impact factor: 8.317

9.  Immunoglobulins in adult sepsis and septic shock.

Authors:  Susanne Toussaint; Herwig Gerlach
Journal:  Curr Infect Dis Rep       Date:  2012-10       Impact factor: 3.725

10.  Analysis of the sputum and inflammatory alterations of the airways in patients with common variable immunodeficiency and bronchiectasis.

Authors:  Andrea Cristina Pereira; Cristina M Kokron; Beatriz Mangueira Saraiva Romagnolo; Claudia Simeire Albertini Yagi; Paulo Hilário Nascimento Saldiva; Geraldo Lorenzi Filho; Elnara Marcia Negri
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.